摘要
对我院从1997年1月至2002年12月住院的535例非瓣膜性持续心房颤动(简称房颤)患者病历资料进行逐项调查,分析房颤病因、抗血栓治疗及并发血栓栓塞性疾病情况.结果:病因以高血压最常见(38.5%),其次为冠心病(34.6%).使用华法令52例(9.7%),维持INR在2.0～3.0范围,无1例出现血栓栓塞性疾病及严重出血.使用阿斯匹林331例(61.9%),用量为平均75 mg/d出现血栓栓塞性疾病76例(占23%).未使用任何抗血栓治疗者152例(28.4%),出现血栓栓塞性疾病36例(23.7%).结论 :华法令能明显减少房颤相关血栓栓塞性疾病的发生,小剂量阿斯匹林则无此作用.
Five hundred and thirty-five cases with nonvalvular persistent atrial fibrillation from January 1997 to December 2002 in our hospital were retrospectively analyzed on the cause of atrial fibrillation, effect of anti-thrombo therapy and occurrence of thrombo-embolism. Results ：52 cases （9.7%） were treated with warfarin and maintained the international rate （INR） at 2.0 - 3.0 and nobody showed the symptom of thrombo-embolism and serious bleeding. While in 331 cases （ 61. 9% ） treated with aspirin （ avreaging 75 mg/d） and 152 cases （ 28.4% ） without use anti-thrombo therapy, thrombo-embolism was found in 76 （23%） and 36 （23.7%） patients respectively. Conclusion： Warfarin can significantly reduce the incidence of atrial fibrillation affiliated thrombo-embolism , while aspirin（75mg/d） can not prevent the occurrence of atrial fibrillation affiliated thrombo-embolism. [ Chinese Journal of Cardiac Pacing and Electrophysiology,2005,19 （5） ：351 - 352 ]
出处
《中国心脏起搏与心电生理杂志》
2005年第5期351-352,共2页
Chinese Journal of Cardiac Pacing and Electrophysiology
